These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38168093)

  • 1. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.
    Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C
    Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
    Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR
    Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: report of two cases.
    Chrisinger JSA; Wehrli B; Dickson BC; Fasih S; Hirbe AC; Shultz DB; Zadeh G; Gupta AA; Demicco EG
    Virchows Arch; 2020 Nov; 477(5):725-732. PubMed ID: 32556562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological study of epithelioid and spindle cell rhabdomysarcoma with EWSR1/FUS-TFCP2 fusion].
    Li HL; Mo CH; Xie L; Wu YX; Zeng M; Mao RJ
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):58-63. PubMed ID: 38178748
    [No Abstract]   [Full Text] [Related]  

  • 5. Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.
    Agaram NP; Zhang L; Sung YS; Cavalcanti MS; Torrence D; Wexler L; Francis G; Sommerville S; Swanson D; Dickson BC; Suurmeijer AJH; Williamson R; Antonescu CR
    Am J Surg Pathol; 2019 May; 43(5):695-702. PubMed ID: 30720533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
    Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M
    Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
    Fanburg-Smith JC; Smith JD; Flemming DJ
    Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation.
    Le Loarer F; Cleven AHG; Bouvier C; Castex MP; Romagosa C; Moreau A; Salas S; Bonhomme B; Gomez-Brouchet A; Laurent C; Le Guellec S; Audard V; Giraud A; Ramos-Oliver I; Cleton-Jansen AM; Savci-Heijink DC; Kroon HM; Baud J; Pissaloux D; Pierron G; Sherwood A; Coindre JM; Bovée JVMG; Larousserie F; Tirode F
    Mod Pathol; 2020 Mar; 33(3):404-419. PubMed ID: 31383960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2.
    Hiemenz MC; Kaur J; Kuang Z; Huang RSP; Harries L; Metzger D; Schiavone K; Millis SZ; Lin DI; Lechpammer M; Decker B; Mata DA; Reddy A; Parke M; Lee EY; Cui X; Iwenofu OH; Buehler D; Henderson L; Baldwin EM; Boikos SA; Ramkissoon SH; Smith SC
    Genes Chromosomes Cancer; 2023 Aug; 62(8):460-470. PubMed ID: 36862145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
    Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior.
    Tsuda Y; Dickson BC; Swanson D; Sung YS; Zhang L; Meyers P; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2020 May; 59(5):286-294. PubMed ID: 31756779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
    Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
    J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging
    Brcic I; Scheipl S; Bergovec M; Leithner A; Szkandera J; Sotlar K; Suda AJ; Smolle MA; Kraus T; Rosenberg AE; Liegl-Atzwanger B; Igrec J
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyosarcoma With
    Zhong P; Wei S; Xiao H; Zeng Y
    Int J Surg Pathol; 2024 Jun; 32(4):758-766. PubMed ID: 37545350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyosarcoma With
    Ishiyama T; Kato I; Ito J; Matsumura M; Saito K; Kawabata Y; Kato S; Takeyama M; Fujii S
    Int J Surg Pathol; 2023 Aug; 31(5):805-812. PubMed ID: 36437645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyosarcoma with TFCP2 Rearrangement or Typical Co-expression of AE1/AE3 and ALK: Report of Three New Cases in the Head and Neck Region and Literature Review.
    Gallagher KPD; Roza ALOC; Tager EMJR; Mariz BALA; Soares CD; Rocha AC; Abrahão AC; Romañach MJ; Carlos R; Hunter KD; Lopes MA; Vargas PA; Santos-Silva AR
    Head Neck Pathol; 2023 Jun; 17(2):546-561. PubMed ID: 36374445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma.
    Li BX; David LL; Davis LE; Xiao X
    J Biol Chem; 2022 Oct; 298(10):102434. PubMed ID: 36041632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel FUS::NFATC4 fusion detected in a sarcoma with morphological features overlapping with NFATC2 sarcomas.
    Klubíčková N; Gross JM; Comová K; Kuruc J; Michal M
    Histopathology; 2024 Jan; 84(2):413-415. PubMed ID: 37813649
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
    Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
    Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.